clinical_trials
Moderna mRNA vaccine almost halves the risk of skin cancer returning
Confidence95·multiple reportsImportance97NP-EVT-20261023-E886B27
Nature, Published online: 23 October 2026; doi:10.1038/d41586-026-03417-0 Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.
Read the original at the primary source
Moderna mRNA vaccine almost halves the risk of skin cancer returning
Mohana Basu · 10/23/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —